What's the difference between nanobodies and conventional monoclonal antibodies?

Hi Javier, thanks for your question. Nanobodies are ~1/10th the size of conventional monoclonal antibodies, they have a small, flexible paratope (antigen binding site), and lack a light chain. These features makes nanobodies extremely soluble and stable, simple to manufacture and store, and amenable to modifications, e.g., oligomerization.

We will cover the benefits of nanobodies and the differences between nanobodies and conventional monoclonal antibodies in the webinar.

Cheers,

Fred